Navigation Links
Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
Date:4/24/2008

its geographical reach, we will benefit greatly from Michael's expertise and knowledge."

Dr Rosenblatt added:

"Shire stands out in the global pharmaceutical industry with its differentiated model, impressive growth record and exciting pipeline. I'm very pleased to be joining the Shire team at this time in the Company's development."

There are no details that are required to be disclosed under paragraph 9.6.13(1-6) of the Listing Rules of the Financial Services Authority.

Notes to Editors

Further background on Michael Rosenblatt

Fuller Albright Young Investigator Award for 'outstanding scientific achievement' (1986)
Vincent du Vigneaud Award in peptide chemistry and biology

Chairman's Award, Merck (1989)

Soma Weiss Award of the Harvard Medical Society (1973)

Citation of Appreciation, Japan Endocrine Society (1988)

Chaired the Gordon Conference on Chemistry and Biology of peptides

Served on the NIH Physiological Chemistry Study Section On the NIH Board of Scientific Councilors of the National Institute of Diabetes and Digestive and Kidney Diseases

Elected to the American Society of Clinical Investigation

Association of American Physicians

Fellowship in the American Association for the Advancement of Science (1993)

President of the American Societyy of Bone and Mineral Researc

Elected to the Association of Osteobiology (1994)

Testified before a US Senate Hearing on US biomedical research priorities (1997)

Shire PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise
'/>"/>

SOURCE Shire PLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
3. Genstar Names Michael Hurt to Its Strategic Advisory Board
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
6. Pharmasset Appoints Michael Rogers as Chief Development Officer
7. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
8. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
9. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
10. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
11. John Marshall and Kevin McGuinness Appointed to Ellex Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...
(Date:12/11/2009)... Gwathmey, Inc., a pre-clinical contract research ... aureus, and cardiovascular disease announces a new CEO. ... Rosalie Dunn, Ph.D., has joined Gwathmey as Chief ... years of experience working with small businesses and ... Dr. Dunn managed multimillion dollar portfolios for the ...
(Date:12/10/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced today ... 15,000,000 shares of its common stock at a price ... also granted to the underwriters a 30-day option to ... stock to cover overallotments, if any. The offering ... to customary closing conditions. ,, J. P. Morgan Securities ...
(Date:12/10/2009)... National Institutes of Health (NIH), awarded a $2.18 million grant ... non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. ... ... (PRWEB) December 10, 2009 -- The National Eye Institute (NEI), ... a $2.18 million grant to Aciont Inc. to help fund ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3
... in the Second Quarter of 2008, SAN ... that the U.S. Food and Drug Administration,s (FDA) ... drug designation for,levofloxacin solution for inhalation for the ... other bacteria in patients,with cystic fibrosis. Levofloxacin is ...
... Set to Dramatically Improve Airway Inflammatory Disease ... Personalized Inflammation Control, NEW PROVIDENCE, N.J., March 4 ... MINO (http://www.nioxmino.com ), a,hand- held point-of-care device for ... the U.S. Food and Drug Administration (FDA).,Physicians in the ...
... Inc. (Nasdaq,CM: INSM), a developer of follow-on biologics and biopharmaceuticals, today,reported results ... 2007 and Recent Company Highlights, -- Follow-on Biologics Program ... Stimulating Factor or ... products to enter clinical trials in 2008; ...
Other Biology Technology:Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis 2Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis 3FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 2FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 3FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 8Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 9Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 10Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 11
(Date:12/11/2009)... species of wild apples that could be an ancestor ... and Central Asia. A new study comparing the diversity ... Georgia and Armenia with previously collected varieties originating in ... a core collection that will make M. orientalis ... , To identify and record the genetic diversity of ...
(Date:12/11/2009)... Pike, an associate professor of anthropology at the University ... northern Kenya to understand how violence shapes the health ... results of her and her colleagues, research," Documenting the ... of northern Kenya: A conceptual framework," is currently published ... Medicine , in collaboration with the British medical journal ...
(Date:12/11/2009)... ORFruit growers, profits have traditionally been limited ... where growing seasons can be short. Thanks ... varieties are being introduced that offer growers ... offseasonresulting in economic bonuses for both producers ... varieties of blackberry called "primocane-fruiting", which bear ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2UA-led study grapples with health effects of low-intensity warfare 2New management methods extend blackberry season 2SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2If You Want Help From a Chimp Youll Have to Ask 59437 1If You Want Help From a Chimp Youll Have to Ask 59437 2Are Commercial Genetic Tests Worth Taking 3F 59435 1Are Commercial Genetic Tests Worth Taking 3F 59435 2Are Commercial Genetic Tests Worth Taking 3F 59435 3
... COLLEGE STATION, Aug. 6, 2008 Think researchers know ... known as E. coli? Think again. "E. coli has ... one-fourth of these remain unknown," says Dr. Deborah Siegele, ... specializes in carrying out research using the bacterium. , ...
... NJIT and University of Sao Paulo today announced a ... safe, building block chemical derived from corn known as ... forward in developing applications and markets for corn-based chemistry. ... right to work with companies interested in sub-licensing this ...
... world in ,a different way from the rest of ... numbers or letters as ,having colors or days of ... normally in the world. Now, researchers at the ,California ... in which individuals hear sounds, such as tapping, ,beeping, ...
Other Biology News:GIANT-Coli: A novel method to quicken discovery of gene function 2Iowa Corn Promotion Board, NJIT to license breakthrough, safe bio-plastic alternative 2Caltech neurobiologists discover individuals who 'hear' movement 2Caltech neurobiologists discover individuals who 'hear' movement 3
... DNA Engine Dyad thermal cycler is ... (PCR). The chassis accommodates a variety ... assemblies), which hold different types and ... graphical programming with point-and-click navigation. Peltier ...
... IHC Select Immunophosphatase Secondary Detection System is ... Select Prediluted Primary Antibody reagents, which contain ... identification of antigens by light microscopy in ... Detection System may also be used with ...
... FLISP Assay with SR-101 Labeled Substrates ... • Accurately measure serine protease activation ... • B-Bridge's FLISP Kits utilize cell-permeable, ... (FLISPs) to measure chymotrypsin-like activity in ...
From the company that first brought you the chromatin immunoprecipitation (ChIP) kit, a new and improved kit, EZ-ChIP, is now available to make your experiments easier, quicker, and most importantly,...
Biology Products: